Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment

Ischemic cardiovascular diseases have a high incidence and high mortality worldwide. Therapeutic advances in the last decades have reduced cardiovascular mortality, with antithrombotic therapy being the cornerstone of medical treatment. Yet, currently used antithrombotic agents carry an inherent ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Barriuso, Ignacio, Worner, Fernando, Vilahur, Gemma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699470/
https://www.ncbi.nlm.nih.gov/pubmed/36421932
http://dx.doi.org/10.3390/jcdd9110397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699470/
https://www.ncbi.nlm.nih.gov/pubmed/36421932
http://dx.doi.org/10.3390/jcdd9110397

Ejemplares similares